Tivity Health Inc (TVTY) Receives $33.00 Average Price Target from Brokerages

Tivity Health Inc (NASDAQ:TVTY) has earned an average recommendation of “Buy” from the eleven research firms that are presently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $33.00.

A number of research analysts recently commented on the company. Zacks Investment Research upgraded Tivity Health from a “hold” rating to a “buy” rating and set a $27.00 price objective on the stock in a report on Wednesday, December 26th. BidaskClub lowered Tivity Health from a “sell” rating to a “strong sell” rating in a report on Monday, March 11th. ValuEngine lowered Tivity Health from a “hold” rating to a “sell” rating in a report on Tuesday, December 11th. Jefferies Financial Group dropped their target price on Tivity Health to $29.00 and set a “buy” rating on the stock in a report on Wednesday, February 20th. Finally, Chardan Capital reissued a “buy” rating and issued a $31.00 target price (down previously from $41.00) on shares of Tivity Health in a report on Friday, February 1st.

NASDAQ:TVTY traded up $0.42 during trading hours on Wednesday, hitting $17.98. 85,095 shares of the stock were exchanged, compared to its average volume of 1,124,134. Tivity Health has a 52-week low of $16.25 and a 52-week high of $41.46. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.08. The firm has a market cap of $721.19 million, a P/E ratio of 7.66, a price-to-earnings-growth ratio of 0.73 and a beta of 1.01.

Tivity Health (NASDAQ:TVTY) last issued its earnings results on Tuesday, February 19th. The company reported $0.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.57 by $0.16. The business had revenue of $153.04 million for the quarter, compared to analysts’ expectations of $153.66 million. Tivity Health had a return on equity of 30.19% and a net margin of 16.30%. On average, research analysts forecast that Tivity Health will post 2.33 earnings per share for the current year.

In other news, Director Bradley S. Karro acquired 2,900 shares of Tivity Health stock in a transaction that occurred on Friday, March 22nd. The stock was purchased at an average price of $16.54 per share, for a total transaction of $47,966.00. Following the completion of the transaction, the director now directly owns 24,696 shares in the company, valued at $408,471.84. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Sara Finley acquired 2,000 shares of Tivity Health stock in a transaction that occurred on Wednesday, March 20th. The stock was purchased at an average price of $17.25 per share, with a total value of $34,500.00. The disclosure for this purchase can be found here. Company insiders own 0.73% of the company’s stock.

A number of institutional investors have recently modified their holdings of the business. BlackRock Inc. increased its holdings in Tivity Health by 3.8% in the fourth quarter. BlackRock Inc. now owns 6,172,669 shares of the company’s stock valued at $153,144,000 after buying an additional 224,313 shares in the last quarter. Vanguard Group Inc. grew its stake in Tivity Health by 0.3% in the 3rd quarter. Vanguard Group Inc. now owns 5,788,356 shares of the company’s stock worth $186,095,000 after acquiring an additional 17,212 shares during the period. Vanguard Group Inc grew its stake in Tivity Health by 0.3% in the 3rd quarter. Vanguard Group Inc now owns 5,788,356 shares of the company’s stock worth $186,095,000 after acquiring an additional 17,212 shares during the period. JPMorgan Chase & Co. grew its stake in Tivity Health by 91.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,545,523 shares of the company’s stock worth $81,838,000 after acquiring an additional 1,214,918 shares during the period. Finally, Neuberger Berman Group LLC grew its stake in Tivity Health by 11.7% in the 3rd quarter. Neuberger Berman Group LLC now owns 2,505,075 shares of the company’s stock worth $80,538,000 after acquiring an additional 262,305 shares during the period.

About Tivity Health

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement, and group retiree plans; and Prime fitness, a fitness facility access program through commercial health plans and employers.

See Also: Is it Safe to Invest in Commodities?

Analyst Recommendations for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.